In addition, sodium orthovanadate also overcomes sorafenib resistance in HCC cells by reduction of HIF-1α/HIF-2α protein expression and their nuclear translocation, resulting in downregulation of their downstream genes, including VEGF, LDHA and GLUT1 (Jiang et al., 2018). This evidence concerns the gene EPAS1 and hepatocellular carcinoma.